Nut and Peanut Hypersensitivity
Nut and Peanut Hypersensitivity
Explore linked clinical trials. Standard reference: MESH:M00062872340 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Oral Food Challenge Biomarkers (SAFER) | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, allergic disease, food allergy, immune system disorder | Recruiting | Not stated | 2026-10-08 | NCT07279467 | |
| Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg | Egg Hypersensitivity, Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Recruiting | Not applicable | 2026-10-08 | NCT06260956 | |
| Safety of MOON101 for the Treatment of Peanut Allergy | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Active, not recruiting | Phase 1 | 2026-10-05 | NCT07580898 | |
| A 52-week Study of Remibrutinib in IgE-mediated Food Allergy | Cow's Milk Allergy, Egg Hypersensitivity, Hypersensitivity, Immediate, Milk Hypersensitivity, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Recruiting | Phase 3 | 2026-09-25 | NCT07768371 | |
| A Randomized Controlled Trial of Oral Immunotherapy Versus Allergen Avoidance in Children Under 2 Years With Food Allergy | Hypersensitivity, Immediate, Nut Hypersensitivity, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Not yet recruiting | Not applicable | 2026-09-17 | NCT07825662 | |
| Efficacy of Tezepelumab in Peanut Oral Immunotherapy | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Recruiting | Phase 2 | 2026-09-16 | NCT07015996 | |
| Efficacy, Safety and Pharmacokinetics of LP-003 in Peanut Allergic Patients | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Not yet recruiting | Phase 2 | 2026-08-25 | NCT07785063 | |
| Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Recruiting | Phase 1 | 2026-08-25 | NCT07287033 | |
| Flow CAST® Peanut Trial | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Not yet recruiting | Not stated | 2026-08-20 | NCT07775430 | |
| Multi-Food Oral Immunotherapy for Peanut and Tree Nuts | Hypersensitivity, Immediate, Nut Hypersensitivity, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Not yet recruiting | Not applicable | 2026-08-13 | NCT07764159 | |
| Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy | Egg Hypersensitivity, Hypersensitivity, Immediate, Milk Hypersensitivity, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Recruiting | Phase 2 | 2026-07-28 | NCT07220811 | |
| Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers) | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, allergic disease, food allergy, immune system disorder | Active, not recruiting | Phase 3 | 2026-07-22 | NCT07003919 | |
| Single Ascending and Multiple Ascending Dose Study of LCA-0061 | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Recruiting | Phase 1 | 2026-07-14 | NCT07701954 | |
| UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Recruiting | Phase 1 / Phase 2 | 2026-06-25 | NCT07349212 | |
| Pathway to Peanut Tolerance | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Recruiting | Not applicable | 2026-05-19 | NCT07592780 | |
| Predictors of Persistent Peanut Allergy at Age 5 Years | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Enrolling by invitation | Not stated | 2026-05-15 | NCT02497261 | |
| Using Commonly Available Food Products To Treat Food Allergy | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Active, not recruiting | Not applicable | 2026-05-13 | NCT05503446 | |
| Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety | Cow's Milk Allergy, Egg Hypersensitivity, Hypersensitivity, Immediate, Milk Hypersensitivity, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Recruiting | Not applicable | 2026-05-07 | NCT06256146 | |
| Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Recruiting | Phase 1 / Phase 2 | 2026-04-24 | NCT07117669 | |
| UNC Cashew Sublingual Immunotherapy | Hypersensitivity, Immediate, Nut Hypersensitivity, Nut and Peanut Hypersensitivity, food allergy, immune system disorder | Not yet recruiting | Phase 2 | 2026-04-14 | NCT07170540 | |
| Food Oral Immunotherapy for Peanut Allergy | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Active, not recruiting | Not stated | 2026-04-09 | NCT04222491 | |
| Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Active, not recruiting | Phase 1 | 2026-03-13 | NCT05476497 | |
| Comparing Standard and Autoclaved Peanut Oral Immunotherapy in People With Peanut Allergy | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Not yet recruiting | Phase 2 | 2026-03-03 | NCT07439406 | |
| A Long Term, Observational Follow-Up Study of Children and Young People Who Underwent an 18-Month Course of Oral Immunotherapy Treatment for Peanut, Egg or Milk Allergy (5-15 Years Post-Treatment) | Egg Hypersensitivity, Hypersensitivity, Immediate, Milk Hypersensitivity, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Recruiting | Not stated | 2026-02-02 | NCT07359183 | |
| Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Active, not recruiting | Phase 3 | 2026-01-22 | NCT05741476 |